Literature DB >> 6165779

Corticoids and cultured human epidermal keratinocytes: specific intracellular binding and clinical efficacy.

M Ponec, J A Kempenaar, E R De Kloet.   

Abstract

Cytosol of cultured human epidermal keratinocytes contains macromolecules, that bind corticoids with high affinity. Binding constants were in the same range for cultured keratinocytes originating from different individuals and did not change during serial cell cultivation. At 0 degree C and using 3H-triamcinolone acetonide as ligand, we obtained the following values; apparent Bmax = 160- 250 fmoles/mg protein and Kdiss = 3.1-5.0 nM; with 3H-dexamethasone Bmax = 200-350 fmoles/mg protein, Kdiss = 6.0-11.1 nM, and with 3H-hydrocortisone Bmax = 140-220 fmoles/mg protein, Kdiss = 17-25 nM. There was an indication that the binding capacity of the receptor system is higher the younger the age of the skin donor. A number of steroids and corticoids commonly used in dermatological practice were tested with respect to displacement of 3H-triamcinolone acetonide, 3H-dexamethasone, and 3H-hydrocortisone from binding sites in cytosol. Good correlation between clinical efficacy and specific binding was observed for all 3 ligands. Other steroids such as 17-beta estradiol and nandrolone did not show any affinity for the corticoid binding system. Progesterone displace 3H-corticoids from their binding sites, but the IC50 was of one order of magnitude larger.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6165779     DOI: 10.1111/1523-1747.ep12525761

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  20 in total

1.  Characterization of the human spr2 promoter: induction after UV irradiation or TPA treatment and regulation during differentiation of cultured primary keratinocytes.

Authors:  S Gibbs; F Lohman; W Teubel; P van de Putte; C Backendorf
Journal:  Nucleic Acids Res       Date:  1990-08-11       Impact factor: 16.971

2.  Glucocorticoid receptor localization in human epidermal cells.

Authors:  M Serres; J Viac; D Schmitt
Journal:  Arch Dermatol Res       Date:  1996-03       Impact factor: 3.017

3.  Glucocorticoid-induced alteration of beta-adrenergic adenylate cyclase response of epidermis.

Authors:  A Ohkawara; H Iizuka
Journal:  Arch Dermatol Res       Date:  1985       Impact factor: 3.017

4.  Effects of UV, 4-NQO and TPA on gene expression in cultured human epidermal keratinocytes.

Authors:  T Kartasova; B J Cornelissen; P Belt; P van de Putte
Journal:  Nucleic Acids Res       Date:  1987-08-11       Impact factor: 16.971

5.  Novel protein in human epidermal keratinocytes: regulation of expression during differentiation.

Authors:  T Kartasova; G N van Muijen; H van Pelt-Heerschap; P van de Putte
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

6.  The involvement of protein kinase C in proliferation and differentiation of human keratinocytes--an investigation using inhibitors of protein kinase C.

Authors:  L Hegemann; J Kempenaar; M Ponec
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017

7.  Biphasic entry of glucocorticoids into cultured human skin keratinocytes and fibroblasts.

Authors:  M Ponec; J A Kempenaar
Journal:  Arch Dermatol Res       Date:  1983       Impact factor: 3.017

8.  Interdependent transcription control elements regulate the expression of the SPRR2A gene during keratinocyte terminal differentiation.

Authors:  D F Fischer; S Gibbs; P van De Putte; C Backendorf
Journal:  Mol Cell Biol       Date:  1996-10       Impact factor: 4.272

9.  Cholesterol sulfate uptake and outflux in cultured human keratinocytes.

Authors:  M Ponec; M L Williams
Journal:  Arch Dermatol Res       Date:  1986       Impact factor: 3.017

10.  Isolation, characterization, and UV-stimulated expression of two families of genes encoding polypeptides of related structure in human epidermal keratinocytes.

Authors:  T Kartasova; P van de Putte
Journal:  Mol Cell Biol       Date:  1988-05       Impact factor: 4.272

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.